Compass Therapeutics Inc. (CMPX): Price and Financial Metrics


Compass Therapeutics Inc. (CMPX): $2.80

0.10 (+3.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CMPX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

CMPX Stock Price Chart Interactive Chart >

Price chart for CMPX

CMPX Price/Volume Stats

Current price $2.80 52-week high $5.80
Prev. close $2.70 52-week low $1.25
Day low $2.71 Volume 347,600
Day high $2.84 Avg. volume 173,095
50-day MA $2.22 Dividend yield N/A
200-day MA $2.60 Market Cap 283.60M

Compass Therapeutics Inc. (CMPX) Company Bio


Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel bispecific targeting PD-1 and PD-L1, and a portfolio of bispecific and monoclonal antibodies at various stages of pre-clinical development. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.


CMPX Latest News Stream


Event/Time News Detail
Loading, please wait...

CMPX Latest Social Stream


Loading social stream, please wait...

View Full CMPX Social Stream

CMPX Price Returns

1-mo -7.28%
3-mo 124.00%
6-mo -4.11%
1-year -42.86%
3-year N/A
5-year N/A
YTD -11.67%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.3923 seconds.